Navigation Links
Patient's weight not linked to success of fibroid surgery
Date:11/19/2009

Obese patients are no more likely to have post-operative complications than those of average weight when undergoing robotic surgery to remove uterine fibroids, according to a study at Henry Ford Hospital.

Myomectomy is a procedure that removes uterine fibroids, leaving the uterus intact and preserving the ability for future pregnancies.

"Performing laparoscopic myomectomy on an obese patient can present difficulties for the most experienced gynecologic surgeon," says David Eisenstein, M.D., division head, Minimally Invasive Gynecologic Surgery, at Henry Ford Health System in Detroit, and co-author of the study. "However, this challenge can now be overcome with the assistance of surgical robots that provide the surgeon with three-dimensional images, improved instrument dexterity and better precision."

The study was presented today at the 38th Global Congress of Minimally Invasive Gynecology in Orlando.

In the U.S., the percentage of adults who are obese, defined as a body mass index (BMI) of more than 30, doubled from 1980 to 2000. Since 1991, the number of obese adults has increased by 74 percent, with nearly 23 million being women.

BMI is a numerical value of a person's weight in relation to height. The numbers are good indicators of healthy weights for adult men and women, regardless of body frame size. BMIs of more than 30 are associated with significantly increased health risks in some people.

The study followed 77 patients who underwent robot-assisted laparoscopic myomectomy from January 2005 through November 2008 at Henry Ford Hospital in Detroit.

Patients involved in the study had overall similar demographics. Thirty-two of the patients (more than 40 percent) had a BMI of more than 30. The study evaluated the impact of BMI on procedure time, estimated blood loss and length of post-operative hospital stay. Obesity was not shown to be a risk factor for poor surgical outcome in patients who had undergone the robotic myomectomy procedure.

Minimally invasive laparoscopic and robotic gynecologic surgery techniques allow surgeons to perform operations without the need for large incisions on the abdomen. By avoiding such incisions, these techniques improve the safety of surgery, lessen complications, and reduce postoperative pain and recovery time for a quicker return to daily life and health. Henry Ford's gynecologic surgeons conduct ongoing research investigations to advance the use of robotic surgery techniques.


'/>"/>

Contact: Sally Ann Brown
sbrown2@hfhs.org
248-514-8687
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. Multidisciplinary meeting on urological cancers aims to benefit cancer patients
2. How to execute dietary management in eating disorder patients
3. Older E-Patients Prefer Facts, Not Friendship from Health Organizations Communicating Via Social Media, According to Path of the Blue Eye Project Survey
4. Morphine May Help Tumors Spread in Cancer Patients
5. Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose
6. Drug for erectile dysfunction improves heart function in young heart-disease patients
7. Niacin Adds No Benefit for Statin Patients: Study
8. Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation
9. Bay Area Plastic Surgeon Reaches Out to Patients with New, State-of-the-Art Website
10. News brief: Adverse symptom reporting by patients vs. clinicians
11. Cancer patients and doctors report drug side effects differently
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... DC (PRWEB) , ... April ... ... Association (ATA) is thrilled to announce the ATA 2017 President’s Awards recipients, ... innovation and demonstrated superior healthcare delivery. , The ATA 2017 President’s ...
(Date:4/26/2017)... ... , ... Infertility may be a result of an underlying ... women become pregnant upon treating their diagnosis. , To properly diagnose ... We can provide the necessary information to diagnose and treat your problem. ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... ecosystem and domain expertise for sponsors and CROs to speed clinical development, ... management (RTSM) software platform. Bioclinica AGILE RTSM provides seamless clinical ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, ... cells) Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition ...
(Date:4/25/2017)... ... ... Lake Park Dental is now accepting new patients with crooked teeth who ... the help of this highly-effective, yet convenient system, patients can straighten their teeth and ... pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology: